4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide CAS:139756-02-8

4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide

Chemical Name:4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide
CAS.NO:  139756-02-8
Synonyms:
4-Amino-1-methyl-3-n-propyl-5-pyrazolecarboxamide
4-Amino-1-methyl-3-N-propyl-1H-pyrazole-5-carboxamide
1H-Pyrazole-5-carboxamide,4-amino-1-methyl-3-n-propyl
4-amino-2-methyl-5-propylpyrazole-3-carboxamide

Molecular Formula: C8H14N4O
Molecular Weight: 182.22300

Physical and Chemical Properties:
Density: 1.32g / cm3
Boiling point: 325.9ºC at 760mmHg
Melting point: 98-101ºC
Flash point: 150.9ºC
Refractive index: 1.618

Specification:
Appearance:White powder
Purity:≥99%
Water(k.f):<0.5%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:-20ºC Freezer.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Sildenafil citrate CAS:171599-83-0



We are professional 4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide manufacturer and 4-amino-2-methyl-5-propylpyrazole-3-carboxamide supplier in China, We offer quality 4-Amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide you can fully trust, also we have India factory and producer of 4-Amino-1-methyl-3-N-propyl-1H-pyrazole-5-carboxamide,Pls send inquiry of 4-Amino-1-methyl-3-n-propyl-5-pyrazolecarboxamide CAS:139756-02-8 to info@nbinno.com if you have any interests, thank you!


Related News: China has a complete upstream and downstream industry chain, lower costs, and good talent reserves. It is one of the few industries in China that has an advantage in international competition.6092-54-2 Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.(2S,3aR,7aS)-Octahydroindole-2-carboxylic acid CAS:145438-94-4 The government is leveraging its large patient population to push non-domestic drugs companies to cut prices to their lowest level globally.64248-59-5 Targets within the tumor microenvironment may include both plasma membrane proteins as well as proteins typically secreted into the extracellular space.The program will run alongside our ongoing Phase 3 INSPIRE Trial, and is expected to continue until commercial launch in such countries.